作者: Qiong-yan Lin , Yi-feng Wang , Hui-nan Weng , Xiu-jie Sheng , Qing-ping Jiang
关键词: Agonist 、 Gonadotropin-releasing hormone 、 Ovarian cancer 、 Internal medicine 、 Cisplatin 、 Gonadotropin-releasing hormone agonist 、 Endocrinology 、 Anti-Müllerian hormone 、 Medicine 、 Ovary 、 Chemotherapy
摘要: Background and objective Gonadotropin-releasing hormone (GnRH) plays an important role in the regulation of ovarian function cancer cell growth. In this study, we determined whether administration GnRH agonist (GnRHa), triporelin, prior to cisplatin treatment affects and/or prevents cisplatin-induced damage.